More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...

In its Phase II, double-blind, multicenter, randomized dose-ranging study, 142 subjects with moderate-to-severe plaque psoriasis were randomized to placebo or 10, 23, 75 or 150 mg of ixekizumab.

The following is a summary of “Global Delphi consensus on treatment goals for generalised pustular psoriasis,” published in the January 2025 issue of Dermatology by Barker et al. Generalized pustular ...

A 21-year-old Muslim, the product of a consanguineous marriage (paternal and maternal grandmothers were sisters) developed progressive papular and erythematosquamous rash over his abdomen on ...

Clinical and histological findings of palmoplantar pustulosis (PPP ... As expected, our patient’s pustular lesions resolved rapidly in response to secukinumab therapy. However, PG, an uncommon ...

Donald Trump is now the 47th president of the United States, as well as the 45th president, a businessman - and a man who knows how to put on a show. Former presidents, Trump family members, tech ...

The fires continue to burn, and the full extent of the damage is still unknown. These latest photos show what's left of places thousands of people call home: What caused the massive blaze in ...

8 An example of the distribution of these side effects is seen in a study performed on palmoplantar psoriasis, in which 20 of 54 patients presented prolonged erythema (48-72 hours) with a mild ...

Secukinumab has demonstrated results of long-term safety and efficacy in the treatment of pediatric generalized pustular psoriasis (GPP), according to a recent study published in the Journal of ...

IN THIS cohort study, genetic testing in 142 patients with palmoplantar keratoderma from 76 families identified 27 disease-causing variants across 13 genes, highlighting the role of genetics in ...